Beauty brands are quietly retiring the phrase "anti-aging" — and replacing it with "longevity." The shift is more than cosmetic wordplay. It signals a fundamental change in how the industry understands, measures, and targets skin aging at a biological level.
For years, the beauty industry sold the promise of turning back the clock. Creams that erased wrinkles. Serums that "fought" the signs of age. The vocabulary was combative, corrective, and — increasingly — out of step with how consumers think about growing older. Today, a new word has taken over the conversation: longevity. And behind this semantic pivot lies a genuine scientific transformation.
Anti-aging is out, longevity skincare is in
The term "anti-aging" has developed a problem. According to Jean-Claude Le Joliff, cosmétologue and president of La Cosmétothèque, the phrase carries a negative charge that modern consumers no longer respond to. Where "anti-aging" implied a battle against something inevitable, "longevity" frames the same process as aspirational — a goal to pursue rather than a decline to resist.
The shift has been building for several years. Brands have gradually scrubbed the old vocabulary from their packaging, their campaigns, and their communications. The change is not simply about tone. It reflects a deeper repositioning: from correcting visible damage after it appears to acting on the biological causes of skin aging before any sign becomes visible.
Any cosmetic claim — including “longevity” — must be backed by scientific proof. Claiming to prevent a phenomenon that hasn’t yet appeared is one of the most complex challenges in cosmetic regulation today.
This regulatory dimension matters. Proving that a product prevents something invisible is significantly harder than demonstrating it reduces the appearance of an existing wrinkle. The beauty industry is now navigating that tension directly, which is precisely why the science behind longevity claims has become so rigorous.
Biomarkers: the new language of skin biology
The most concrete expression of this shift is the emergence of skin biomarkers as a central tool in formulation and product development. Lancôme, one of the first major brands to invest heavily in this area, has conducted research identifying more than 260 cutaneous biomarkers linked to the parameters of skin longevity. These are measurable biological signals — proteins, molecular markers — that reflect the actual biological age of the skin, not just its appearance.
From 260 biomarkers to 5 key measurements
Working with the Korean start-up NanoEntek, Lancôme developed a device capable of analyzing these biomarkers directly from the surface of the skin. Specifically, the tool works by reading proteins from the stratum corneum — the outermost layer of the epidermis — to estimate the skin's biological age. Out of the full map of 260 biomarkers, the device focuses on 5 key biomarkers that serve as reliable indicators of skin aging dynamics.
Annie Black, scientific director at Lancôme, has been central to this research. The collaboration with NanoEntek represents a new model for the industry: pairing a luxury beauty house with a biotech start-up to produce diagnostic tools that were previously confined to clinical settings.
Predictive markers and the prevention logic
What makes this approach particularly significant is that some of the biomarkers being measured are predictive. They don't just describe the current state of the skin — they signal future aging issues before they materialize. This is the scientific foundation for the prevention logic that underlies longevity skincare.
The practical implication is real: the map of 260 biomarkers now guides which active ingredients are selected, how they are combined, and how formulas are structured. The approach also relies on new marking techniques that make previously invisible skin phenomena observable. For consumers thinking about makeup choices for mature skin, understanding what's happening beneath the surface adds a layer of context that pure aesthetics never could.
Prevention and correction: a moving balance
One of the most nuanced points in the longevity framework is that prevention and correction are not opposites — they exist on a continuum. The younger the skin, the more a longevity-focused formula can lean into prevention, acting on biological mechanisms before any damage is done. But as skin ages, the corrective component necessarily grows in importance.
This means longevity skincare is not a one-size-fits-all proposition. A formula designed for skin in its thirties will prioritize different biomarker targets than one designed for skin in its fifties or sixties. The science allows for this kind of precision in a way that the old "anti-aging" catch-all never did.
- Acts on biological causes before visible signs appear
- Uses measurable biomarkers to guide formulation
- Predictive markers allow truly preventive action
- More precise targeting by age and skin profile
- Proving prevention of invisible phenomena is regulatorily complex
- Corrective needs still grow with age, limiting pure prevention
- Consumer communication of biomarker science remains a challenge
The shift also resonates culturally. Ten or twenty years ago, the dominant beauty narrative was about looking younger. Today, consumers — particularly women over 45 — are less interested in erasure and more interested in vitality. That distinction matters to brands. Choosing the right foundation for mature skin or adapting a makeup routine to aging features is part of the same cultural conversation: aging on your own terms, with science as a tool rather than a battle plan.
The industry's new scientific standard
The Lancôme-NanoEntek collaboration is a signal of where the broader beauty industry is heading. Biomarker analysis, once the domain of clinical dermatology and pharmaceutical research, is entering the consumer skincare space. The use of stratum corneum protein analysis to estimate biological skin age represents a genuine methodological leap — one that reframes what a skincare brand can credibly claim to do.
cutaneous biomarkers identified by Lancôme’s longevity research
Brands that adopt this framework are committing to a higher evidentiary standard. Every longevity claim must be substantiated — not with before-and-after photos of surface texture, but with measurable changes in biological markers. That's a harder promise to make and a harder one to keep. But it's also a more honest one.
The concept of skin longevity is also beginning to intersect with broader wellness thinking. The same curiosity driving consumers toward Japanese dietary habits for long-term health is shaping how they approach skincare: less reactive, more systemic, and rooted in the biology of aging rather than its cosmetic symptoms. The vocabulary of beauty has changed. The science backing it up is changing even faster.
